AGPI - Lipides et signalisation cellulaire
AGPI - Lipides et signalisation cellulaire
AGPI - Lipides et signalisation cellulaire
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
11 études<br />
<strong>AGPI</strong> n-3 : Immunosuppresseurs<br />
Owerview of double-blind, randomised studles of the effect of supplementation<br />
with ω-3 polyunsaturated fatty-acids (n-3 PUFA) in patients with rheumatoid arthritis.<br />
No. of No. of Duration n-3 PUFA Main findings<br />
patients patients compl<strong>et</strong>ed weeks supplement (g/day)<br />
52 37 12 3.0 no. tender joints<br />
morning stiffness<br />
40 3 14 4.5 no. tender joints, time to fatigue<br />
LTB 4 and LTB 5<br />
65 49 24 3.2 no. tender joints, no.swollen joints<br />
6.4 grip strength , morning stiffness<br />
LTB4 and interleukin-1<br />
12 12 4 2.7 Ritchie joint index, morning stiffness<br />
grip strength<br />
48 33 52 0.5 daily intake of NSAID<br />
60 46 12 5.2 tender joints, grip strength LTB 4<br />
16 14 12 3.4 tenders joints, morning stiffness<br />
LTB 4 and LTB 5<br />
48 43 26 3.0 dally intake of NSAID<br />
improvment of global assessment<br />
74 67 16 5.8 moming stiffness<br />
55 51 12 3.6 moming stiffness, no. Tender joints
Change language